Core Viewpoint - Nanjing Pharmaceutical Co., Ltd. maintains its credit rating of "AA+" with a stable outlook for both its corporate and convertible bond ratings, indicating consistent financial health and stability [1][3]. Group 1: Credit Rating Details - The previous credit rating for the company was "AA+" with a stable outlook, and the same rating applies to the convertible bond "Nanyao Convertible Bond" [1][3]. - The current tracking rating results show no change from the previous rating, reaffirming the company's strong creditworthiness [3]. Group 2: Rating Agency and Methodology - The credit rating was conducted by China Chengxin International Credit Rating Co., Ltd., based on a comprehensive analysis of the company's operational status and industry conditions [1].
南京医药: 南京医药关于可转换公司债券2025年度跟踪评级结果的公告